Learn More
BRD7 Polyclonal Antibody, Bethyl Laboratories
Rabbit Polyclonal Antibody
Supplier: Bethyl Laboratories, Inc A302304AT
Description
The recommended shelf life for this product is 1 year from date of receipt. Application Note: For IHC, epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Based on 100% sequence identity, this antibody is predict
BRD7 acts both as coactivator and as corepressor. For example, it activates the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. In addition, it is required for TP53-mediated cell-cycle arrest in response to oncogene activation. BRD7 promotes acetylation of TP53 at Lys-382, and thereby promotes efficient recruitment of TP53 to target promoters, inhibiting cell cycle progression from G1 to S phase.Specifications
| BRD7 | |
| Polyclonal | |
| TBS with 0.1% BSA and 0.09% sodium azide | |
| Q9NPI1 | |
| BRD7 | |
| Between 601 and 651 | |
| 20 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
| Immunohistochemistry, Western Blot | |
| Unconjugated | |
| BRD7 | |
| Bromodomain-containing protein 7, 75 kDa bromodomain protein, Protein CELTIX-1, BRD7, BP75, CELTIX1 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 29117 | |
| 4° C | |
| Liquid |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.